CRISPR/Cas9 holds promising potential for addressing the genetic anomalies associated with cystic fibrosis, allowing precise gene editing to mitigate the disease's detrimental effects. However, further research and thorough ethical considerations are necessary to ensure the responsible and safe implementation of this technology for cystic fibrosis patients.
(In 1-3 complete sentences, write the points of the opposing viewpoint to your original claim.)
Some argue that the CRISPR/Cas9 technology is still in its early stages and its long-term effects on the human genome are not fully understood, thus it may lead to unintended consequences or unpredictable side effects. Additionally, there are concerns about the accessibility and affordability of this technology, as it may only be available to a privileged few, exacerbating social inequalities in healthcare. Lastly, there is a moral and ethical debate about whether we should be intervening in the human genetic code, as it raises questions about the potential for genetic enhancement and designer babies.
1. The potential risks and unintended consequences of using CRISPR/Cas9 in cystic fibrosis patients need to be thoroughly evaluated before any implementation, as there may be unforeseen complications or side effects that could worsen the condition.
2. From an ethical standpoint, there are concerns about the consent process, potential inequalities in access to gene editing technology, and the implications of altering the human germline.
3. The cost of implementing CRISPR/Cas9 for cystic fibrosis treatment might be prohibitive, making it inaccessible to a significant portion of the population, thereby exacerbating existing health disparities.